"author:hjsh200219" matching MCP servers:

• cti-mcp

  hjsh200219

  F

  license

  -

  quality

  C

  maintenance

  Enables to analyze Korean pharma/biotech stocks using clinical trial data from ClinicalTrials.gov and market data from Naver Finance, providing 100-point scoring, decision labels, and technical indicators.

  Last updated 2026-05-01